ShareValue scores for 8037.HK: Valuation 43, Quality 36, Growth 27, Health 31.

8037.HK
HKEX

China Biotech Services Holdings Ltd

HK$0.65(+3.17%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 15%
Valuation
43
Fair Value
Price vs Value
Quality
36
Weak
Business Strength
Growth
27
Weak
Revenue & Earnings
Health
31
Stressed
Financial Stability
Momentum
60
Neutral
Price Trend

Company Details

About

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products; insurance brokerage services; provision of boron neutron capture therapy treatment services, as well as provision of logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong. Address: Suites 1904-05A, Causeway Bay, Hong Kong

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026